Young and old more likely to face severe flu. Here’s why doctors think it happens
Canadians have been getting sick enough with seasonal flu to land in hospital, say doctors with suggestions on who is most at risk and what it could mean for festive gatherings.
Alzheimer’s drug slowed cognitive decline overall in trial, but with major side effects for some
An experimental Alzheimer’s disease drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients, according to new data presented on Tuesday.
WHO says it’s using ‘mpox’ to avoid racist monkeypox name
The World Health Organization has renamed monkeypox as mpox, citing concerns the original name of the decades-old animal disease could be construed as discriminatory and racist.
Patients wait months for Pap test results as labs juggle high demand, staff shortage
Delays to process Pap test results are being felt across much of the country. The COVID-19 pandemic played a role in creating a backlog of all kinds of screening tests — but industry insiders say the problem is made worse by ongoing long-term staffing issues in the Canadian lab sector.
Why there’s excitement and skepticism about new Alzheimer’s drug lecanemab
Despite decades of research and billions of dollars, no treatment has ever definitively proven to slow the progression of Alzheimer’s disease. Two pharmaceutical companies have developed a drug that they say does just that.
Flu rising sharply in Canada, Dr. Theresa Tam says
Flu is rising sharply in Canada as another respiratory virus that was hitting young children starts to decline, Canada’s chief public health officer says.
Flu increasing more sharply than past seasons, chief public health officer says
Flu is rising sharply in Canada as another respiratory virus that was hitting young children starts to decline, Canada’s chief public health officer says.